Elasmogen: BGF, SNIB and Scottish Enterprise invest 8 million in Elasmogen
Aberdeen-based biopharmaceutical company will now be able to develop its next-generation drugs through pre-clinical trials
Read full article »
Elasmogen is a Scotland-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer and inflammatory diseases.
Read more